Effects of streptococcal pyrogenic exotoxin B on pathogenesis of Streptococcus pyogenes

Journal of the Formosan Medical Association

Volumn 107, Issue 9, 2008, Pages 677-685

  Chiang Ni, Chuan ^a   Wu, Jiunn Jong ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Group A streptococcus; Pathogenesis; SpeB

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; BACTERIAL PROTEIN; BACTERIAL TOXIN; CEPHALOSPORIN; CLINDAMYCIN; COMPLEMENT; CYSTEINE PROTEINASE; ERYTHROMYCIN; IMMUNOGLOBULIN; PENICILLIN G; PYROGENIC EXOTOXIN B; SCLEROPROTEIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; APOPTOSIS; BACTERIAL STRAIN; BACTERIAL VIRULENCE; DISEASE SEVERITY; GENETIC VARIABILITY; HUMAN; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SECRETION; REVIEW; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES;

EID: 54449083249     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-6646(08)60112-6     Document Type: Review

References (86)

1. Cunningham MW. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 2000;13:470-511.
2. Cunningham MW. Pathogenesis of group A streptococcal infections and their sequelae. Adv Exp Med Biol 2008; 609:29-42.
3. Huang YC, Chiu CH, Chang LY, et al. Characteristics of group A streptococcal bacteremia with comparison between children and adults. J Microbiol Immunol Infect 2001;34:195-200.
4. Lin MH, Chang PF, Fong WK, et al. Epidemiological and clinical features of group A streptococcus pharyngitis in children. Acta Paediatr Taiwan 2003;44:274-8.
5. Bisno AL, Brito MO, Collins CM. Molecular basis of group A streptococcal virulence. Lancet Infect Dis 2003; 3:191-200.
6. Chen CY, Luo SC, Kuo SC, et al. Maturation processing and characterization of streptopain. J Biol Chem 2003;278: 17336-43.
7. Hauser AR, Schlievert PM. Nucleotide sequence of the streptococcal pyrogenic exotoxin type B gene and relationship between the toxin and the streptococcal proteinase precursor. J Bacteriol 1990;172:4536-42.
8. Nomizu M, Pietrzynski G, Kato T, et al. Substrate specificity of the streptococcal cysteine protease. J Biol Chem 2001;276:44551-6.
9. Allhorn M, Olsen A, Collin M. EndoS from Streptococcus pyogenes is hydrolyzed by the cysteine proteinase SpeB and requires glutamic acid 235 and tryptophans for IgG glycan-hydrolyzing activity. BMC Microbiol 2008;8:3.
10. Berge A, Björck L. Streptococcal cysteine proteinase releases biologically active fragments of streptococcal surface proteins. J Biol Chem 1995;270:9862-67.
11. Chaussee MS, Cole RL, van Putten JP. Streptococcal erythrogenic toxin B abrogates fibronectin-dependent internalization of Streptococcus pyogenes by cultured mammalian cells. Infect Immun 2000;68:3226-32.
12. Eriksson A, Norgren M. Cleavage of antigen-bound immunoglobulin G by SpeB contributes to streptococcal persistence in opsonizing blood. Infect Immun 2003;71: 211-7.
13. Johnston KH, Zabriskie JB. Purification and partial characterization of the nephritis strain-associated protein from Streptococcus pyogenes, group A. J Exp Med 1986;163: 697-712.
14. Kapur V, Majesky MW, Li LL, et al. Cleavage of interleukin 1 beta (IL-1 beta) precursor to produce active IL-1 beta by a conserved extracellular cysteine protease from Streptococcus pyogenes. Proc Natl Acad Sci USA 1993;90:7676-80.
15. Kapur V, Majesky MW, Li LL, et al. A conserved Streptococcus pyogenes extracellular cysteine protease cleaves human fibronectin and degrades vitronectin. Microb Pathog 1993;15:327-46.
16. Kuo CF, Lin YS, Chuang WJ, et al. Degradation of complement 3 by streptococcal pyrogenic exotoxin B inhibits complement activation and neutrophil opsonophagocytosis. Infect Immun 2008;76:1163-9.
17. Nyberg P, Rasmussen M, von Pawel-Rammingen U, et al. SpeB modulates fibronectin-dependent internalization of Streptococcus pyogenes by efficient proteolysis of cell-wall-anchored protein F1. Microbiology 2004;150:1559-69.
18. Rasmussen M, Björck L. Proteolysis and its regulation at the surface of Streptococcus pyogenes. Mol Microbiol 2002; 43:537-44.
19. Svensson MD, Sjöbring U, Luo F, et al. Roles of the plasminogen activator streptokinase and the plasminogen-associated M protein in an experimental model for streptococcal impetigo. Microbiology 2002;148:3933-45.
20. Wolf BB, Gibson CA, Kapur V, et al. Proteolytically active streptococcal pyrogenic exotoxin B cleaves monocytic cell urokinase receptor and releases an active fragment of the receptor from the cell surface. J Biol Chem 1994;269: 30682-7.
21. Burns EH, Marciel, AM, Musser JM Activation of a 66-kilodalton human endothelial cell matrix metalloprotease by Streptococcus pyogenes extracellular cysteine protease. Infect Immun 1996;64:4744-50.
22. Tamura F, Nakagawa R, Akuta T, et al. Proapoptotic effect of proteolytic activation of matrix metalloproteinases by Streptococcus pyogenes thiol proteinase (Streptococcus pyrogenic exotoxin B). Infect Immun 2004;72:4836-47.
23. Herwald H, Collin M, Müller-Esterl W, et al. Streptococcal cysteine proteinase releases kinins: a virulence mechanism. J Exp Med 1996;184:665-73.
24. Collin M, Svensson MD, Sjöholm AG, et al. EndoS and SpeB from Streptococcus pyogenes inhibit immunoglobulin-mediated opsonophagocytosis. Infect Immun 2002;70: 6646-51.
25. Collin M, Olsén A. Effect of SpeB and EndoS from Streptococcus pyogenes on human immunoglobulins. Infect Immun 2001; 69:7187-9.
26. Terao Y, Mori Y, Yamaguchi M, et al. Group A streptococcal cysteine protease degrades C3 (C3b) and contributes to evasion of innate immunity. J Biol Chem 2008;283: 6253-60.
27. Cole JN, McArthur JD, McKay FC, et al. Trigger for group A streptococcal M1T1 invasive disease. FASEB J 2006;20: 1745-7.
28. Liu TY, Elliott SD. Streptococcal proteinase: The zymogen to enzyme transformation. J Biol Chem 1965;240:1138-42.
29. Kansal RG, Nizet V, Jeng A, et al. Selective modulation of superantigen-induced responses by streptococcal cysteine protease. J Infect Dis 2003;187:398-407.
30. Raeder R, Woischnik M, Podbielski A, et al. A secreted streptococcal cysteine protease can cleave a surface-expressed M1 protein and alter the immunoglobulin binding properties. Res Microbiol 1998;149:539-48.
31. Nooh MM, Aziz RK, Kotb M, et al. Streptococcal mitogenic exotoxin, SmeZ, is the most susceptible M1T1 streptococcal superantigen to degradation by the streptococcal cysteine protease, SpeB. J Biol Chem 2006;281:35281-8.
32. Wei L, Pandiripally V, Gregory E, et al. Impact of the SpeB protease on binding of the complement regulatory proteins factor H and factor H-like protein 1 by Streptococcus pyogenes. Infect Immun 2005;73:2040-50.
33. Ji Y, Carlson B, Kondagunta A, et al. Intranasal immunization with C5a peptidase prevents nasopharyngeal colonization of mice by the group A streptococcus. Infect Immun 1997;65:2080-7.
34. Ji Y, McLandsborough L, Kondagunta A, et al. C5a peptidase alters clearance and trafficking of group A streptococci by infected mice. Infect Immun 1996:64:503-10.
35. Walker MJ, Hollands A, Anderson-Smith ML, et al. DNase Sda1 provides selection pressure for a switch to invasive group A streptococcal infection. Nat Med 2007;13:981-5.
36. Batsford SR, Mezzano S, Mihatsch M, et al. Is the nephritogenic antigen in post-streptococcal glomerulonephritis pyrogenic exotoxin B (SPE B) or GAPDH? Kidney Int 2005;68:1120-9.
37. Cu GA, Mezzano S, Bannan JD, et al. Immunohistochemical and serological evidence for the role of streptococcal proteinase in acute post-streptococcal glomerulonephritis. Kidney Int 1998;54:819-26.
38. Luo YH, Kuo CF, Huang KJ, et al. Streptococcal pyrogenic exotoxin B antibodies in a mouse model of glomerulonephritis. Kidney Int 2007;72:716-24.
39. Nordstrand A, Norgren M, Ferretti JJ, et al. Streptokinase as a mediator of acute post-streptococcal glomerulonephritis in an experimental mouse model. Infect Immun 1998;66: 315-21.
40. Parra G, Rodríguez-Iturbe B, Batsford S, et al. Antibody to streptococcal zymogen in the serum of patients with acute glomerulonephritis: a multicentric study. Kidney Int 1998; 54:509-17.
41. Chaussee MS, Liu J, Stevens DL, et al. Genetic and phenotypic diversity among isolates of Streptococcus pyogenes from invasive infections. J Infect Dis 1996;173:901-8.
42. Talkington DF, Schwartz B, Black CM, et al. Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome. Infect Immun 1993;61:3369-74.
43. Kansal RG, McGeer A, Low DE, et al. Inverse relation between disease severity and expression of the streptococcal cysteine protease, SpeB, among clonal M1T1 isolates recovered from invasive group A streptococcal infection cases. Infect Immun 2000;68:6362-9.
44. Shiseki M, Miwa K, Nemoto Y, et al. Comparison of pathogenic factors expressed by group A streptococci isolated from patients with streptococcal toxic shock syndrome and scarlet fever. Microb Pathog 1999;27:243-52.
45. 3. Proc Natt Acad Sci USA 1999;96:242-7.
46. Hsueh PR, Wu JJ, Tsai PJ, et al. Invasive group A streptococcal disease in Taiwan is not associated with the presence of streptococcal pyrogenic exotoxin genes. Clin Infect Dis 1998;26:584-9.
47. LaPenta D, Rubens C, Chi E, et al. Group A streptococci efficiently invade human respiratory epithelial cells. Proc Natl Acad Sci USA 1994;91:12115-9.
48. Osterlund A, Engstrand L. An intracellular sanctuary for Streptococcus pyogenes in human tonsillar epithelium-studies of asymptomatic carriers and in vitro cultured biopsies. Acta Otolaryngol 1997;117:883-8.
49. Osterlund A, Popa R, Nikkilä T, et al. Intracellular reservoir of Streptococcus pyogenes in vivo: a possible explanation for recurrent pharyngotonsillitis. Laryngoscope 1997;107: 640-7.
50. Thulin P, Johansson L, Low DE, et al. Viable group A streptococci in macrophages during acute soft tissue infection. PLoS Med 2006;3:e53.
51. Sela S, Barzilai A. Why do we fail with penicillin in the treatment of group A streptococcus infections? Ann Med 1999;31:303-7.
52. Marouni MJ, Sela S. Fate of Streptococcus pyogenes and epithelial cells following internalization. J Med Microbiol 2004;53:1-7.
53. Sela S, Neeman R, Keller N, et al. Relationship between asymptomatic carriage of Streptococcus pyogenes and the ability of the strains to adhere to and be internalised by cultured epithelial cells. J Med Microbiol 2000;49:499-502.
54. Neeman R, Keller N, Barzilai A, et al. Prevalence of internalisation-associated gene, prtF1, among persisting group A streptococcus strains isolated from asymptomatic carriers. Lancet 1998;352:1974-7.
55. Kaplan EL, Chhatwal GS, Rohde M. Reduced ability of penicillin to eradicate ingested group A streptococci from epithelial cells: clinical and pathogenetic implications. Clin Infect Dis 2006;43:1398-406.
56. Tsai PJ, Kuo CF, Lin KY, et al. Effect of group A streptococcal cysteine protease on invasion of epithelial cells. Infect Immun 1998;66:1460-6.
57. Jadoun J, Eyal O, Sela S. Role of CsrR, hyaluronic acid, and SpeB in the internalization of Streptococcus pyogenes M type 3 strain by epithelial cells. Infect Immun 2002;70: 462-9.
58. Tsai PJ, Lin YS, Kuo CF, et al. Group A streptococcus induces apoptosis in human epithelial cells. Infect Immun 1999;67:4334-9.
59. Nakagawa I, Nakata M, Kawabata S, et al. Cytochrome c-mediated caspase-9 activation triggers apoptosis in Streptococcus pyogenes-infected epithelial cells. Cell Microbiol 2001;3:395-405.
60. 3 integrin and Fas. Infect Immun 2008;76: 1349-57.
61. Nakagawa I, Nakata M, Kawabata S, et al. Transcriptome analysis and gene expression profiles of early apoptosis-related genes in Streptococcus pyogenes-infected epithelial cells. Cell Microbiol 2004;6:939-52.
62. Tsai WH, Chang CW, Chuang WJ, et al. Streptococcal pyrogenic exotoxin B-induced apoptosis in A549 cells is mediated by a receptor- and mitochondrion-dependent pathway. Infect Immun 2004;72:7055-62.
63. Chang CW, Tsai WH, Chuang WJ, et al. The fate of SpeB after internalization and its implication in SpeB-induced apoptosis.J Biomed Sci 2007;14:419-27.
64. Kobayashi SD, Braughton KR, Whitney AR, et al. Bacterial pathogens modulate an apoptosis differentiation program in human neutrophils. Proc Natl Acad Sci USA 2003;100: 10948-53.
65. Kuo CF, Wu JJ, Tsai PJ, et al. Streptococcal pyrogenic exotoxin B induces apoptosis and reduces phagocytic activity in U937 cells. Infect Immun 1999;67:126-30.
66. Viera NT, Romero MJ, Montero MK, et al. Streptococcal erythrogenic toxin B induces apoptosis and proliferation in human leukocytes. Kidney Int 2001;59:950-8.
67. Lukomski S, Burns EH, Wyde PR, et al. Genetic inactivation of an extracellular cysteine protease (SpeB) expressed by Streptococcus pyogenes decreases resistance to phagocytosis and dissemination to organs. Infect Immun 1998; 66:771-6.
68. Chiang-Ni C, Wang CH, Tsai PJ, et al. Streptococcal pyrogenic exotoxin B causes mitochondria damage to polymorphonuclear cells preventing phagocytosis of group A streptococcus. Med Microbiol Immunol 2006;195:55-63.
69. Tsao N, Tsai WH, Lin YS, et al. Streptococcal pyrogenic exotoxin B cleaves properdin and inhibits complement-mediated opsonophagocytosis. Biochem Biophys Res Commun 2006;339:779-84.
70. Kuo CF, Wu JJ, Lin KY, et al. Role of streptococcal pyrogenic exotoxin B in the mouse model of group A streptococcal infection. Infect Immun 1998;66:3931-5.
71. Lukomski S, Sreevatsan S, Amberg C, et al. Inactivation of Streptococcus pyogenes extracellular cysteine protease significantly decreases mouse lethality of serotype M3 and M49 strains. J Clin Invest 1997;99:2574-80.
72. Kuo CF, Luo YH, Lin HY, et al. Histopathologic changes in kidney and liver correlate with streptococcal pyrogenic exotoxin B production in the mouse model of group A streptococcal infection. Microb Pathog 2004;36:273-85.
73. Lukomski S, Montgomery CA, Rurangirwa J, et al. Extracellular cysteine protease produced by Streptococcus pyogenes participates in the pathogenesis of invasive skin infection and dissemination in mice. Infect Immun 1999; 67:1779-88.
74. Ashbaugh CD, Wessels MR. Absence of a cysteine protease effect on bacterial virulence in two murine models of human invasive group A streptococcal infection. Infect Immun 2001;69:6683-8.
75. Saouda M, Wu W, Conran P, et al. Streptococcal pyrogenic exotoxin B enhances tissue damage initiated by other Streptococcus pyogenes products. J Infect Dis 2001;184: 723-31.
76. Kazmi SU, Kansal R, Aziz, RK, et al. Reciprocal, temporal expression of SpeA and SpeB by invasive M1T1 group A streptococcal isolates in vivo. Infect Immun 2001;69: 4988-95.
77. Raeder R, Harokopakis E, Hollingshead S, et al. Absence of SpeB production in virulent large capsular forms of group A streptococcal strain 64. Infect Immun 2000;68: 744-51.
78. Aziz RK, Pabst MJ, Jeng A, et al. Invasive M1T1 group A streptococcus undergoes a phase-shift in vivo to prevent proteolytic degradation of multiple virulence factors by SpeB. Mol Microbiol 2004;51:123-34.
79. Engleberg NC, Heath A, Miller A, et al. Spontaneous mutations in the CsrRS two-component regulatory system of Streptococcus pyogenes result in enhanced virulence in a murine model of skin and soft tissue infection. J Infect Dis 2001;183:1043-54.
80. Graham MR, Smoot LM, Migliaccio CA, et al. Virulence control in group A streptococcus by a two-component gene regulatory system: global expression profiling and in vivo infection modeling. Proc Natl Acad Sci USA 2002; 99:13855-60.
81. Heath A, DiRita VJ, Barg NL, et al. A two-component regulatory system, CsrR-CsrS, represses expression of three Streptococcus pyogenes virulence factors, hyaluronic acid capsule, streptolysin S, and pyrogenic exotoxin B. Infect Immun 1999;67:5298-305.
82. Sumby P, Whitney AR, Graviss EA, et al. Genome-wide analysis of group A streptococci reveals a mutation that modulates global phenotype and disease specificity. PLoS Pathog 2006;2:e5.
83. Federle MJ, McIver KS, Scott JR. A response regulator that represses transcription of several virulence operons in the group A streptococcus. J Bacteriol 1999;181:3649-57.
84. 2+. Proc Natl Acad Sci USA 2003;100: 4227-32.
85. Sumby P, Porcella SF, Madrigal AG, et al. Evolutionary origin and emergence of a highly successful clone of serotype M1 group A streptococcus involved multiple horizontal gene transfer events.J Infect Dis 2005;192:771-82.
86. Aziz RK, Edwards RA, Taylor WW, et al. Mosaic prophages with horizontally acquired genes account for the emergence and diversification of the globally disseminated M1T1 clone of Streptococcus pyogenes. J Bacteriol 2005;187:3311-8.